Home Cart 0 Sign in  
X

[ CAS No. 53554-29-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 53554-29-3
Chemical Structure| 53554-29-3
Chemical Structure| 53554-29-3
Structure of 53554-29-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 53554-29-3 ]

Related Doc. of [ 53554-29-3 ]

Alternatived Products of [ 53554-29-3 ]

Product Details of [ 53554-29-3 ]

CAS No. :53554-29-3 MDL No. :MFCD00023234
Formula : C8H10N2O3S Boiling Point : -
Linear Structure Formula :- InChI Key :HDIWKNXVBQPJCO-UHFFFAOYSA-N
M.W : 214.24 Pubchem ID :239049
Synonyms :

Calculated chemistry of [ 53554-29-3 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.38
Num. rotatable bonds : 4
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 52.67
TPSA : 97.35 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.15 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.6
Log Po/w (XLOGP3) : 0.65
Log Po/w (WLOGP) : 0.67
Log Po/w (MLOGP) : 0.38
Log Po/w (SILICOS-IT) : 1.77
Consensus Log Po/w : 1.01

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.63
Solubility : 5.01 mg/ml ; 0.0234 mol/l
Class : Very soluble
Log S (Ali) : -2.27
Solubility : 1.15 mg/ml ; 0.00537 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.55
Solubility : 0.609 mg/ml ; 0.00284 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.01

Safety of [ 53554-29-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 53554-29-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 53554-29-3 ]
  • Downstream synthetic route of [ 53554-29-3 ]

[ 53554-29-3 ] Synthesis Path-Upstream   1~12

  • 1
  • [ 53554-29-3 ]
  • [ 5909-24-0 ]
YieldReaction ConditionsOperation in experiment
92% at 60℃; for 3 h; Ethyl 4-hydroxy-2-methylthiopyrimidine-5-carboxylate (30 g, 140 mmol) was added to a three-vial flask.Add 20g of thionyl chloride (168mmol)The reaction was heated to 60°C for 3 hours. After the reaction was complete, it was cooled to 0-5°C. 100 ml of water was added and crystallized at 0-5°C for 1-2 hours. The mixture was filtered and vacuum dried at 50°C to give 30.1 g of white solid product. Yield 92 percent, pure 99.8percent,
77% for 5 h; Heating / reflux A mixture of 4-hydroxy-2-(methylsulfanyl)pyrimidine-5-carboxylic acid ethyl ester (50 g, 0.234 mmol), POC13 (110 mL, 1.17 mmol) and diethylamide (70 mL, 0.28 mmol) was refluxed for 5h. The solvent was removed under vacuum and the residue was dissolved in ice H2O and cautiously neutralized with aqueous NaHCO3. After extraction with EtOAc (3x400 mL), the organic extracts were combined, dried and concentrated to give 4-chloro-2- (methylsulfanyl)pyrimidine-5-carboxylic acid ethyl ester as a yellow solid (42 g, 77percent yield).
77% With trichlorophosphate In acetonitrile for 6 h; Reflux the ethyl 4-hydroxy-2-methylsulfanyl-5-carboxylate obtained in the step S1 (55.6 g, 0.26 mol) was added to 150 mL of acetonitrile.Stir for 25min,Slowly add 135 mL of POCl3 to the reaction solution.After the addition is completed,The reaction solution was heated to reflux for 6 h.Then the reaction solution is slightly cold,The reaction solution was concentrated and the residue was poured into an ice water mixture and stirred.Adjust the pH of the reaction solution to neutral with saturated sodium bicarbonate solution.When a large amount of white solid precipitates, suction filtration is performed.The filter cake is used in turn (135mL × 3),Anhydrous ethanol (30 mL × 3) was rinsed.Then dried in vacuo to give a white solid (47.8 g, 77percent);
40% at 10 - 65℃; for 7 h; Step 2. Preparation of 4-chloro-2-methylsulfanyl-pyrimidine-5-carboxylic acid ethyl ester (B19-2): Neat POCl3 (120 mL) was cooled to 10° C. and treated portion-wise over 4 hours with B19-1 (50 g, 232 mmol) without exceeding a temperature of 25° C. The mixture was then heated at 65° C. After 3 hours the mixture was cooled to 10° C., poured into crushed ice (350 g), treated drop-wise with water (676 mL) under vigorous stirring. The resultant solids were collected and dried under reduced pressure to provide B19-2 as a pale yellow solid. Yield: 22 g, 40percent. 1H NMR (CDCl3): δ 8.95 (s, 1H), 4.44 (q, 2H), 2.62 (s, 3H) and 1.42 (t, 3H).

Reference: [1] Patent: CN108101853, 2018, A, . Location in patent: Paragraph 0015-0018
[2] Patent: WO2006/71940, 2006, A2, . Location in patent: Page/Page column 354
[3] Patent: CN108707141, 2018, A, . Location in patent: Paragraph 0027; 0030; 0039; 0048
[4] Patent: US2009/54395, 2009, A1, . Location in patent: Page/Page column 45-46
[5] Bioorganic and Medicinal Chemistry Letters, 2000, vol. 10, # 15, p. 1645 - 1648
[6] Patent: WO2015/1567, 2015, A1, . Location in patent: Page/Page column 24; 25
[7] Journal of the Chinese Chemical Society, 2018, vol. 65, # 4, p. 445 - 451
  • 2
  • [ 53554-29-3 ]
  • [ 5909-24-0 ]
Reference: [1] Cancer Research, 1959, vol. 19, p. 729,730,731
[2] Journal of the American Chemical Society, 1943, vol. 65, p. 350,352
[3] Cancer Research, 1959, vol. 19, p. 729,730,731
[4] Journal of the American Chemical Society, 1943, vol. 65, p. 350,352
[5] European Journal of Medicinal Chemistry, 2018, vol. 145, p. 673 - 690
  • 3
  • [ 87-13-8 ]
  • [ 53554-29-3 ]
YieldReaction ConditionsOperation in experiment
81%
Stage #1: at 0℃; Inert atmosphere
Stage #2: at 0 - 20℃; Inert atmosphere
To a solution of sodium ethoxide (1.36 g, 20.0 mmol) in ethanol (15 mL) was added S-methylisothiourea sulfate (5.57 g, 40.0 mmol) at 0 °C. After a few minutes, diethyl ethoxymethylenemalonate (4.00 mL, 19.8 mmol) was added. After stirring at 0 °C for 3 h, a solution of sodium ethoxide (1.36 g, 20.0 mmol) in ethanol (15 mL) was added. The resulted solution was stirred at room temperature overnight. Ethanol was removed under reduced pressure and the pale yellow residue was dissolved in water. After filtration, the aqueous filtrate was washed with ether and acidified with acetic acid (10 mL). The organic materials were extracted with CHCl3. The combined organic extracts were washed with brine, dried over MgSO4, and concentrated. Recrystallization of the residue with CHCl3 gave compound 10 (3.44 g, 81percent) as colorless needles. Mp 129-130 °C (CHCl3), lit.16 132-133 °C (benzene/petroleum ether). IR (KBr) 3435, 2902, 2805, 1739, 1701, 1529, 1170 cm-1. δH (400 MHz, CDCl3) 1.42 (3H, t, J 6.8 Hz, CH2CH3), 2.60 (3H, s, SCH3), 4.43 (2H, q, J 6.8 Hz, CH2CH3), 8.75 (1H, s, C4-H). δC (150 MHz, DMSO;d6) 13.0, 14.1, 60.2, 111.7, 157.8, 158.9, 163.6, 168.0. LRMS (EI) m/z 214 (M+). HRMS (EI): M+, found 214.0458. C8H10N2O3S requires 214.0412.
Reference: [1] Tetrahedron, 2011, vol. 67, # 14, p. 2661 - 2669
[2] European Journal of Medicinal Chemistry, 2018, vol. 145, p. 673 - 690
  • 4
  • [ 36239-09-5 ]
  • [ 53554-29-3 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2001, vol. 38, # 1, p. 93 - 98
  • 5
  • [ 2986-19-8 ]
  • [ 87-13-8 ]
  • [ 53554-29-3 ]
Reference: [1] Journal of the American Chemical Society, 1943, vol. 65, p. 350,352
  • 6
  • [ 53114-57-1 ]
  • [ 87-13-8 ]
  • [ 53554-29-3 ]
Reference: [1] American Chemical Journal, 1907, vol. 37, p. 396
  • 7
  • [ 38026-46-9 ]
  • [ 77-78-1 ]
  • [ 53554-29-3 ]
Reference: [1] Journal of the Chemical Society, 1953, p. 4175
  • 8
  • [ 53554-29-3 ]
  • [ 55084-66-7 ]
Reference: [1] Patent: US2014/275023, 2014, A1,
  • 9
  • [ 53554-29-3 ]
  • [ 330784-47-9 ]
Reference: [1] Patent: WO2015/1567, 2015, A1,
[2] Patent: WO2015/1567, 2015, A1,
  • 10
  • [ 53554-29-3 ]
  • [ 330785-81-4 ]
Reference: [1] Patent: WO2015/1567, 2015, A1,
[2] Patent: WO2015/1567, 2015, A1,
[3] Patent: CN108707141, 2018, A,
  • 11
  • [ 53554-29-3 ]
  • [ 330785-84-7 ]
Reference: [1] Patent: WO2015/1567, 2015, A1,
[2] Patent: WO2015/1567, 2015, A1,
  • 12
  • [ 53554-29-3 ]
  • [ 397308-78-0 ]
Reference: [1] Patent: US2014/275023, 2014, A1, . Location in patent: Paragraph 0290; 0291
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 53554-29-3 ]

Avanafil Intermediates

Chemical Structure| 20187-46-6

[ 20187-46-6 ]

Ethyl 4-amino-2-hydroxypyrimidine-5-carboxylate

Chemical Structure| 71-30-7

[ 71-30-7 ]

6-Aminopyrimidin-2(1H)-one

Chemical Structure| 23356-96-9

[ 23356-96-9 ]

L-Prolinol

Chemical Structure| 330785-84-7

[ 330785-84-7 ]

(S)-4-((3-Chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylic acid

Chemical Structure| 87-13-8

[ 87-13-8 ]

Diethyl 2-(ethoxymethylene)malonate

Related Functional Groups of
[ 53554-29-3 ]

Amides

Chemical Structure| 4786-52-1

[ 4786-52-1 ]

Ethyl 6-oxo-1,6-dihydropyrimidine-5-carboxylate

Similarity: 0.79

Chemical Structure| 20651-30-3

[ 20651-30-3 ]

5-Methyl-2-(methylthio)pyrimidin-4(3H)-one

Similarity: 0.78

Chemical Structure| 67383-32-8

[ 67383-32-8 ]

Ethyl 4-hydroxy-2-methylpyrimidine-5-carboxylate

Similarity: 0.74

Chemical Structure| 65754-04-3

[ 65754-04-3 ]

6-Oxo-1,6-dihydropyrimidine-5-carboxylic acid

Similarity: 0.73

Chemical Structure| 89487-99-0

[ 89487-99-0 ]

4-Hydroxy-2-(methylthio)pyrimidine-5-carbonitrile

Similarity: 0.73

Esters

Chemical Structure| 4786-52-1

[ 4786-52-1 ]

Ethyl 6-oxo-1,6-dihydropyrimidine-5-carboxylate

Similarity: 0.79

Chemical Structure| 67383-32-8

[ 67383-32-8 ]

Ethyl 4-hydroxy-2-methylpyrimidine-5-carboxylate

Similarity: 0.74

Chemical Structure| 776-53-4

[ 776-53-4 ]

Ethyl 4-amino-2-(methylthio)pyrimidin-5-carboxylate

Similarity: 0.60

Chemical Structure| 55981-09-4

[ 55981-09-4 ]

2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate

Similarity: 0.59

Chemical Structure| 313535-84-1

[ 313535-84-1 ]

Methyl 4-oxo-3,4-dihydroquinazoline-7-carboxylate

Similarity: 0.57

Sulfides

Chemical Structure| 20651-30-3

[ 20651-30-3 ]

5-Methyl-2-(methylthio)pyrimidin-4(3H)-one

Similarity: 0.78

Chemical Structure| 89487-99-0

[ 89487-99-0 ]

4-Hydroxy-2-(methylthio)pyrimidine-5-carbonitrile

Similarity: 0.73

Chemical Structure| 5751-20-2

[ 5751-20-2 ]

2-(Methylthio)pyrimidin-4(3H)-one

Similarity: 0.67

Chemical Structure| 81560-03-4

[ 81560-03-4 ]

5-Bromo-2-(methylthio)pyrimidin-4(3H)-one

Similarity: 0.63

Chemical Structure| 34170-21-3

[ 34170-21-3 ]

2-(Methylthio)-5,6,7,8-tetrahydroquinazolin-4(3H)-one

Similarity: 0.62

Related Parent Nucleus of
[ 53554-29-3 ]

Pyrimidines

Chemical Structure| 4786-52-1

[ 4786-52-1 ]

Ethyl 6-oxo-1,6-dihydropyrimidine-5-carboxylate

Similarity: 0.79

Chemical Structure| 20651-30-3

[ 20651-30-3 ]

5-Methyl-2-(methylthio)pyrimidin-4(3H)-one

Similarity: 0.78

Chemical Structure| 67383-32-8

[ 67383-32-8 ]

Ethyl 4-hydroxy-2-methylpyrimidine-5-carboxylate

Similarity: 0.74

Chemical Structure| 65754-04-3

[ 65754-04-3 ]

6-Oxo-1,6-dihydropyrimidine-5-carboxylic acid

Similarity: 0.73

Chemical Structure| 89487-99-0

[ 89487-99-0 ]

4-Hydroxy-2-(methylthio)pyrimidine-5-carbonitrile

Similarity: 0.73